Biofrontera Inc. (NASDAQ:BFRI) Short Interest Down 44.9% in December

Biofrontera Inc. (NASDAQ:BFRI) was the target of a significant drop in short interest in December. As of December 31st, there was short interest totalling 292,400 shares, a drop of 44.9% from the December 15th total of 530,600 shares. Approximately 4.7% of the company’s stock are sold short. Based on an average daily trading volume, of 3,010,000 shares, the days-to-cover ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, Benchmark reissued a “buy” rating and issued a $7.00 price objective on shares of Biofrontera in a research report on Friday, November 15th.

Biofrontera Trading Down 3.5 %

Shares of NASDAQ:BFRI traded down $0.04 during trading on Tuesday, reaching $1.09. 38,411 shares of the stock were exchanged, compared to its average volume of 2,010,715. The stock has a 50-day moving average price of $0.99 and a 200-day moving average price of $1.05. The firm has a market cap of $8.45 million, a PE ratio of -0.50 and a beta of 0.27. Biofrontera has a 12 month low of $0.61 and a 12 month high of $2.43.

About Biofrontera

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.